The Dark Side of CRISPR
By Sandy Sufian and Rosemarie Garland-Thomson,
Scientific American
| 02. 16. 2021
Its potential ability to “fix” people at the genetic level is a threat to those who are judged by society to be biologically inferior
Americans have celebrated the fact that the Biden administration is embracing science and returning the country to evidence-based policymaking. We agree that science should guide policy—except in cases where it wouldn’t assist people to live their lives but would, instead, exclude them.
The CRISPR-Cas9 gene-editing technology, for which biochemists Jennifer Doudna and Emmanuelle Charpentier won the Nobel Prize in Chemistry, has the potential to do just that. So do other forms of scientific technologies. We should therefore always be aware of the ethical choices these technologies can pose.
In the case of CRISPR, those choices are complex. CRISPR has many functions; one of these is that it can be used to treat disease. Yet the far-reaching, more fraught promise of this technology—one about which scientists seem at once excited and cautious—lies in its ability to eliminate from the gene pool what medical science identifies as faulty or abnormal genes that cause difference in individual people. Certainly, goes the logic of CRISPR’s promise, the goal of ridding future generations of terrible diseases that cause suffering and death and deplete resources...
Related Articles
By Hannah Devlin, The Guardian | 07.05.2025
Scientists are just a few years from creating viable human sex cells in the lab, according to an internationally renowned pioneer of the field, who says the advance could open up biology-defying possibilities for reproduction.
Speaking to the Guardian, Prof...
By Rob Stein, NPR | 07.16.2025
Scientists can protect children from being born with certain devastating genetic disorders by creating "three-parent" babies, according to the results of a landmark study released Wednesday.
British researchers used the experimental technique to help families have eight children who appear...
By Jessica Hamzelou, MIT Technology Review | 07.18.2025
This week we heard that eight babies have been born in the UK following an experimental form of IVF that involves DNA from three people. The approach was used to prevent women with genetic mutations from passing mitochondrial diseases to...
By Jessica Hamzelou, MIT Technology Review | 07.16.2025
Eight babies have been born in the UK thanks to a technology that uses DNA from three people: the two biological parents plus a third person who supplies healthy mitochondrial DNA. The babies were born to mothers who carry genes...